ReviewDiabetes therapy : research, treatment and education of diabetes and related disorders2024

SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review.

Samuel Seidu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.